Explore
Validate
Learn
Flow cytometryAntibody data
- Antibody Data
- Antigen structure
- References [14]
- Comments [0]
- Validations
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1105948 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Fas Ligand (TNF Superfamily, Member 6) (FASL) antibody (FITC)
- Antibody type
- Monoclonal
- Description
- Protein A agarose
- Reactivity
- Human, Mouse
- Host
- Hamster
- Conjugate
- Green dye
- Isotype
- IgG
- Antibody clone number
- FLIM58
- Vial size
- 50 tests
- Storage
- Store at 2 - 8°C.
Submitted references Fas ligand induces cell-autonomous NF-kappaB activation and interleukin-8 production by a mechanism distinct from that of tumor necrosis factor-alpha.
Interactions between Sec complex and prepro-alpha-factor during posttranslational protein transport into the endoplasmic reticulum.
Chimeric beta2 microglobulin/CD3zeta polypeptides expressed in T cells convert MHC class I peptide ligands into T cell activation receptors: a potential tool for specific targeting of pathogenic CD8(+) T cells.
Pathogen-associated molecular patterns sensitize macrophages to Fas ligand-induced apoptosis and IL-1 beta release.
Prevention of hepatocellular carcinoma development associated with chronic hepatitis by anti-fas ligand antibody therapy.
Prevention and induction of autoimmune exocrinopathy is dependent on pathogenic autoantigen cleavage in murine Sjögren's syndrome.
Cutting edge: Ly49A inhibits TCR/CD3-induced apoptosis and IL-2 secretion.
Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex.
Fas ligand-mediated exocrinopathy resembling Sjögren's syndrome in mice transgenic for IL-10.
Therapeutic effect of an anti-Fas ligand mAb on lethal graft-versus-host disease.
Cell death induced by the Fas/Fas ligand pathway and its role in pathology.
Fas-Fas ligand-based interactions between tumor cells and tumor-specific cytotoxic T lymphocytes: a lethal two-way street.
Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis.
Polymorphism of murine Fas ligand that affects the biological activity.
Imamura R, Konaka K, Matsumoto N, Hasegawa M, Fukui M, Mukaida N, Kinoshita T, Suda T
The Journal of biological chemistry 2004 Nov 5;279(45):46415-23
The Journal of biological chemistry 2004 Nov 5;279(45):46415-23
Interactions between Sec complex and prepro-alpha-factor during posttranslational protein transport into the endoplasmic reticulum.
Plath K, Wilkinson BM, Stirling CJ, Rapoport TA
Molecular biology of the cell 2004 Jan;15(1):1-10
Molecular biology of the cell 2004 Jan;15(1):1-10
Chimeric beta2 microglobulin/CD3zeta polypeptides expressed in T cells convert MHC class I peptide ligands into T cell activation receptors: a potential tool for specific targeting of pathogenic CD8(+) T cells.
Margalit A, Fishman S, Berko D, Engberg J, Gross G
International immunology 2003 Nov;15(11):1379-87
International immunology 2003 Nov;15(11):1379-87
Pathogen-associated molecular patterns sensitize macrophages to Fas ligand-induced apoptosis and IL-1 beta release.
Fukui M, Imamura R, Umemura M, Kawabe T, Suda T
Journal of immunology (Baltimore, Md. : 1950) 2003 Aug 15;171(4):1868-74
Journal of immunology (Baltimore, Md. : 1950) 2003 Aug 15;171(4):1868-74
Prevention of hepatocellular carcinoma development associated with chronic hepatitis by anti-fas ligand antibody therapy.
Nakamoto Y, Kaneko S, Fan H, Momoi T, Tsutsui H, Nakanishi K, Kobayashi K, Suda T
The Journal of experimental medicine 2002 Oct 21;196(8):1105-11
The Journal of experimental medicine 2002 Oct 21;196(8):1105-11
Prevention and induction of autoimmune exocrinopathy is dependent on pathogenic autoantigen cleavage in murine Sjögren's syndrome.
Saegusa K, Ishimaru N, Yanagi K, Mishima K, Arakaki R, Suda T, Saito I, Hayashi Y
Journal of immunology (Baltimore, Md. : 1950) 2002 Jul 15;169(2):1050-7
Journal of immunology (Baltimore, Md. : 1950) 2002 Jul 15;169(2):1050-7
Cutting edge: Ly49A inhibits TCR/CD3-induced apoptosis and IL-2 secretion.
Roger J, Chalifour A, Lemieux S, Duplay P
Journal of immunology (Baltimore, Md. : 1950) 2001 Jul 1;167(1):6-10
Journal of immunology (Baltimore, Md. : 1950) 2001 Jul 1;167(1):6-10
Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex.
Asao H, Okuyama C, Kumaki S, Ishii N, Tsuchiya S, Foster D, Sugamura K
Journal of immunology (Baltimore, Md. : 1950) 2001 Jul 1;167(1):1-5
Journal of immunology (Baltimore, Md. : 1950) 2001 Jul 1;167(1):1-5
Fas ligand-mediated exocrinopathy resembling Sjögren's syndrome in mice transgenic for IL-10.
Saito I, Haruta K, Shimuta M, Inoue H, Sakurai H, Yamada K, Ishimaru N, Higashiyama H, Sumida T, Ishida H, Suda T, Noda T, Hayashi Y, Tsubota K
Journal of immunology (Baltimore, Md. : 1950) 1999 Mar 1;162(5):2488-94
Journal of immunology (Baltimore, Md. : 1950) 1999 Mar 1;162(5):2488-94
Therapeutic effect of an anti-Fas ligand mAb on lethal graft-versus-host disease.
Miwa K, Hashimoto H, Yatomi T, Nakamura N, Nagata S, Suda T
International immunology 1999 Jun;11(6):925-31
International immunology 1999 Jun;11(6):925-31
Cell death induced by the Fas/Fas ligand pathway and its role in pathology.
Waring P, Müllbacher A
Immunology and cell biology 1999 Aug;77(4):312-7
Immunology and cell biology 1999 Aug;77(4):312-7
Fas-Fas ligand-based interactions between tumor cells and tumor-specific cytotoxic T lymphocytes: a lethal two-way street.
Zeytun A, Hassuneh M, Nagarkatti M, Nagarkatti PS
Blood 1997 Sep 1;90(5):1952-9
Blood 1997 Sep 1;90(5):1952-9
Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis.
Hueber AO, Zörnig M, Lyon D, Suda T, Nagata S, Evan GI
Science (New York, N.Y.) 1997 Nov 14;278(5341):1305-9
Science (New York, N.Y.) 1997 Nov 14;278(5341):1305-9
Polymorphism of murine Fas ligand that affects the biological activity.
Kayagaki N, Yamaguchi N, Nagao F, Matsuo S, Maeda H, Okumura K, Yagita H
Proceedings of the National Academy of Sciences of the United States of America 1997 Apr 15;94(8):3914-9
Proceedings of the National Academy of Sciences of the United States of America 1997 Apr 15;94(8):3914-9
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS
